Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. LACRYADEX (oxytétracycline / dexaméthasone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

LACRYADEX (oxytétracycline / dexaméthasone)

Medicine - Posted on Aug 03 2023
Active substance (DCI)
  • LACRYADEX
  • LACRYADEX
history (1)
  • 7/19/23

    LACRYADEX (oxytétracycline / dexaméthasone) - Corticoïde et anti-infectieux ophtalmique

    Inscription : Primo-inscription. L'essentiel Avis favorable au remboursement uniquement dans : le traitement local anti-infl...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • S01CA01
Manufacturer
HORUS PHARMA
Presentation

LACRYADEX 1 mg/5 mg par g, pommade ophtalmique
1 tube aluminium verni de 10 g (CIP : 34009 302 637 2 3)

All our publications
    Bacterial infections Drug therapy Eye diseases Paediatrics Pain - Inflammation

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNrFmN9v2jAQx9/5K6K8JwFKgE6BamPthtRqjII27QWZ5Chmrp36B4T99XMI7WiVqK2pu0ds5+58d/74i6Oz7JY4a+ACM9pzG37ddYDGLMH0pudOJxde1z3r16IVWqODZR2/7jearhMTJETPzWf9OSAq/J9Xl59Bfw/c7deciM1XEMtH65TExP+KxPIKpfkaJ1oznDi3IJcs6bmpkrtRJxKS6yj6G8Z/ixTFEAX7kcPZ1ax1OB4FubEXWFUC+CWiN6VGgRrZjBXnQOUASbhhfFtqehHPmt1Ou17vGrnAYgyCKR7DCMnliLM1TiAp94SIACMni01yDXxNQOZOSo0Hq/hWGBlHK5SN4W5YHvRHPTuQmfTqXqMTtsJTnayw3Q2NXPGDVJU3j95EkM5OWmG7020GQAOCYr5FCWQey7YSJEfxNiaYghd4ehTlvpBgFAyrN2JcImKpblgMHnegJT8c7p7tjwSLlKCtvxKpaaoQz9MNXHPC3kbyHUy4JhfROXtinypCgldGPd1zxVLEObYGTFFZgZeLsWkiBoxKyKorakZEme17EYN4O7N/nhzAh4mRmhMcm0JPY0mBkNPxsJp574uLT0jAlNvjxQ9ME7YRb8+hw7pbij7dobTUaMqTxqx52m03wtD4mP3SZau4pc4VZykEmlBYHAOeIV2wY5Gj+7bc1H3XvmPD7kQVixGBClnlGfJJd+q9CrR2Fuyds2Ki1OiX84lpA31XwLfXu5+lpnHSeyi9Gbxt3Ai6XSsDf33zFwx4geBudU/MkqB4OWKWUqbiQxBsNhtfnxhPIJ0sf8H/wyVxcHPb+0NgRR4UcqkAraXQ58UN+roamh7J5wTEsaJ4//1efJf6kFzBEbUo6G2NscPzt8f2P0VsLezRI8zYc7NTr0hiRm1pJjUvF0xHXRS6rvSCa0B8WyxwxTtNZV9GQfFG1K9FQf4+1K/9BSLEHcY=
tv33JHQ92ayLbdDm